$BLUE Form 8-K

0
577

Form 8-K for BLUEBIRD BIO, INC.


11-Jan-2016

Regulation FD Disclosure, Financial Statements and Exhibits

Item 7.01 Regulation FD DisclosureThe Company will be conducting meetings with investors attending the 34th Annual J.P. Morgan Healthcare Conference in San Francisco beginning on January 11, 2016. As part of these meetings, the Company will deliver the slide presentation attached to this report as Exhibit 99.1, which is incorporated herein by reference.

The information responsive to Item 7.01 of this Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

 

Item 9.01Financial Statements and Exhibits.(d) Exhibits

Exhibit No. Description
99.1 Investor presentation provided by bluebird bio, Inc. on January 11, 2016

ACTIVE/71742392.1


 

LEAVE A REPLY

Please enter your comment!
Please enter your name here